Overall Technical outlook

Price Summary

On 2026-04-09, Jubilant Pharmova Limited's stock opened at 863.45, reached 889.85, hit a low of 852.3, and rose 1.8% to close at 879.0, with 269109 shares traded.
During the 52-week span, the stock hit a high of 1236.3 and a low of 0.0.

Technicals

Support and Resistance: At 879.0, the price for JUBLPHARMA is supported at 821.15 and resisted at 882.7. This indicates a trading range where 821.15 serves as a support level, potentially preventing further decline, while 882.7 could limit upward movement.
JUBLPHARMA supportResistance 57a1cf
Support/Resistance for JUBLPHARMA


Aroon: The AROON is showing a neutral stance, with no definitive indication of an upward or downward trend for JUBLPHARMA. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
JUBLPHARMA aroon 57a1cf
Aroon chart for Jubilant Pharmova Limited


Bol. Bands: The BOLL BANDS is in a neutral stance for JUBLPHARMA, not indicating a clear upward or downward trend. This suggests a period of market indecision, where neither bulls nor bears have the upper hand.
JUBLPHARMA bbands 57a1cf
Bolinger Bands chart for Jubilant Pharmova Limited


Parabolic SAR: The PSAR maintains a bullish outlook, reinforcing a support level that could help uphold the market's upward trend. This suggests that the market is likely to continue climbing, with the support providing a solid base for further gains.
JUBLPHARMA psar 57a1cf
Parabolic Stop and Reverse chart for Jubilant Pharmova Limited


Stochastic: The STOCHASTIC is in a neutral stance, not pointing to a clear trend in either direction. This suggests that the market may be lacking strong momentum, making it difficult to predict the next move.
JUBLPHARMA stoch 57a1cf
Stochastic chart for Jubilant Pharmova Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
JUBLPHARMA trippleSMA 57a1cf
Tripple SMA chart for Jubilant Pharmova Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.